Merck KGaA, Darmstadt, Germany, Strengthens Immuno-Oncology Portfolio through Expansion of F-star Collaboration including LAG-3/PD-L1 Bispecific Antibody

http://www.emdgroup.com

DARMSTADT, Germany, June 4, 2017 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, today announced a new strategic collaboration with biopharmaceutical company…

June 04, 2017 at 04:47PM

http://ift.tt/2rySiQY

from

http://ift.tt/2rySiQY